RNAZ
Transcode Therapeutics, Inc.Company with tickers: RNAZ
CIK
1829635
CUSIP
89357L501
Shares Outstanding
950,302
Investor Relations
https://ir.transcodetherapeutics.com/
13F Activity (30d)
3 filings
3 filers
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Holders: 1
Total Value: $904,753
Total Shares: 101,772
Institutional Ownership Trend
7 quarters
Quarterly Activity
vs Mar 31, 2026
New
1
Increased
0
Decreased
0
Sold Out
5
Unchanged
0
Holder count:
-4
Institutional value:
+366.9%
Shares held:
+352.2%
Top New Positions
vs Mar 31, 2026| Institution | Acquired | Value (USD) | Open |
|---|---|---|---|
| — YA II PN, Ltd. | 101,772 | $904,753 |
Top Sold-Out Positions
vs Mar 31, 2026| Institution | Previously Held | Last Value (USD) | Open |
|---|---|---|---|
| Mega GEODE CAPITAL MANAGEMENT, LLC | 12,740 | $109,690 | |
| Mega VANGUARD CAPITAL MANAGEMENT LLC | 6,545 | $56,352 | |
| Mega VANGUARD FIDUCIARY TRUST CO | 2,982 | $25,675 | |
| Mid Tower Research Capital LLC (TRC) | 228 | $1,963 | |
| Mid SBI Securities Co., Ltd. | 12 | $103 |
| Holder | Value (USD) | % of 13F | Shares | Type | Discretion | Filed | Open | |||
|---|---|---|---|---|---|---|---|---|---|---|
| — YA II PN, Ltd. | $904,753 | 100.00% | 101,772 | Shares | Sole | 2026-04-20 | ||||
| No holders match your search. | ||||||||||